Thalassemia Global Clinical Trials Review, H2, 2016

Publisher Name :
Date: 31-Aug-2016
No. of pages: 192
Inquire Before Buying

GlobalData's clinical trial report, "Thalassemia Global Clinical Trials Review, H2, 2016" provides an overview of Thalassemia clinical trials scenario. This report provides top line data relating to the clinical trials on Thalassemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope


  • The report provides a snapshot of the global clinical trials landscape

  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

  • The Report provides enrollment trends for the past five years

  • Report provides latest news for the past three months


Reasons to buy


  • Assists in formulating key business strategies with regards to investment

  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost

  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

  • Supports understanding of trials count and enrollment trends by country in global therapeutics market

  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Thalassemia Global Clinical Trials Review, H2, 2016

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Five Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Thalassemia to Hematological Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Thalassemia to Hematological Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Thalassemia Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Thalassemia 30
Sep 08, 2016: bluebird bio Opens Phase 3 Study of LentiGlobin Drug Product in Patients with Transfusion-Dependent Beta-Thalassemia 30
Sep 07, 2016: La Jolla Pharmaceutical Company Reports Positive Results from Phase 1 Study of LJPC-401 30
Sep 07, 2016: La Jolla Pharmaceutical Company Announces Agreement with European Medicines Agency on Pivotal Study of LJPC-401 31
Clinical Trial Profile Snapshots 32
Appendix 189
Abbreviations 189
Definitions 189
Research Methodology 190
Secondary Research 190
About GlobalData 191
Contact Us 191
Disclaimer 191
Source 192

List of Tables

Thalassemia Therapeutics, Global, Clinical Trials by Region, 2016* 6
Thalassemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Thalassemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Thalassemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Thalassemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Thalassemia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Thalassemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
Thalassemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
Proportion of Thalassemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 14
Thalassemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Thalassemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Thalassemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 17
Thalassemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Thalassemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Thalassemia Therapeutics, Global, Clinical Trials by Phase, 2016* 20
Thalassemia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
Thalassemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Thalassemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Thalassemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Thalassemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
Thalassemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Thalassemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Thalassemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

Thalassemia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Thalassemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Thalassemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Thalassemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Thalassemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Thalassemia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Thalassemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
Thalassemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
Proportion of Thalassemia to Hematological Disorders Clinical Trials, G7 Countries (%), 2016* 14
Thalassemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Thalassemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Thalassemia to Hematological Disorders Clinical Trials, E7 Countries (%), 2016* 17
Thalassemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Thalassemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
Thalassemia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
Thalassemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
Thalassemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
Thalassemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
Thalassemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
Thalassemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
Thalassemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
Thalassemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Thalassemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
GlobalData Methodology 190

  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 […]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining […]
  • Age Related Macular Degeneration Global Clinical Trials Review, H1, 2017
    Published: 15-Mar-2017        Price: US 2500 Onwards        Pages: 489
    Age Related Macular Degeneration Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Age Related Macular Degeneration Global Clinical Trials Review, H1, 2017" provides an overview of Age Related Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Age Related Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries cond......
  • African Trypanosomiasis Global Clinical Trials Review, H1, 2017
    Published: 15-Mar-2017        Price: US 2500 Onwards        Pages: 36
    African Trypanosomiasis Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "African Trypanosomiasis Global Clinical Trials Review, H1, 2017" provides an overview of African Trypanosomiasis clinical trials scenario. This report provides top line data relating to the clinical trials on African Trypanosomiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report o......
  • Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017
    Published: 15-Mar-2017        Price: US 2500 Onwards        Pages: 44
    Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Adult Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2017" provides an overview of Adult Respiratory Distress Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Adult Respiratory Distress Syndrome. Report includes an overview of trial numbers and their average enrollment in top co......
  • Adult Malignant Glioma Global Clinical Trials Review, H1, 2017
    Published: 15-Mar-2017        Price: US 2500 Onwards        Pages: 34
    Adult Malignant Glioma Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Adult Malignant Glioma Global Clinical Trials Review, H1, 2017" provides an overview of Adult Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on Adult Malignant Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offer......
  • Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017
    Published: 15-Mar-2017        Price: US 2500 Onwards        Pages: 76
    Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Adrenocortical Carcinoma (Adrenal Cortex Cancer) Global Clinical Trials Review, H1, 2017" provides an overview of Adrenocortical Carcinoma (Adrenal Cortex Cancer) clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenocortical Carcinoma (Adrenal Cortex Cancer). Report includes an overview of ......
  • Adrenal Insufficiency Global Clinical Trials Review, H1, 2017
    Published: 15-Mar-2017        Price: US 2500 Onwards        Pages: 69
    Adrenal Insufficiency Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Adrenal Insufficiency Global Clinical Trials Review, H1, 2017" provides an overview of Adrenal Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenal Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers co......
  • Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2017
    Published: 15-Mar-2017        Price: US 2500 Onwards        Pages: 49
    Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2017" provides an overview of Addison's Disease (Primary or Chronic Adrenal Insufficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Addison's Disease (Primary or Chronic Adrenal......
  • Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2017
    Published: 15-Mar-2017        Price: US 2500 Onwards        Pages: 46
    Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2017" provides an overview of Acute Upper Respiratory Tract Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Upper Respiratory Tract Infections. Report includes an overview of trial numbers and their average ......
  • Acute Stress Disorder Global Clinical Trials Review, H1, 2017
    Published: 15-Mar-2017        Price: US 2500 Onwards        Pages: 55
    Acute Stress Disorder Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Acute Stress Disorder Global Clinical Trials Review, H1, 2017" provides an overview of Acute Stress Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Stress Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs